WallStreetZenWallStreetZen

NYSE: ADCT
Adc Therapeutics Sa Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ADCT past revenue growth

How has ADCT's revenue growth performed historically?
Company
-66.86%
Industry
144.63%
Market
17.55%
ADCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ADCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ADCT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ADCT earnings and revenue history

Current Revenue
$69.6M
Current Earnings
-$240.1M
Current Profit Margin
-345.1%

ADCT Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when ADCT announces earnings.

ADCT Return on Assets

Current Company
-53.4%
Current Industry
2.9%
ADCT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ADCT Return on Capital Employed

Current Company
-53.85%
Current Industry
19.5%
ADCT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADCT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ADCT$69.56M-$151.36M-$240.05M+127.56%N/A
AURA$0.00-$73.14M-$76.41MN/AN/A
CRBP$0.00-$41.04M-$44.60M-100.00%N/A
MRSN$36.86M-$163.30M-$171.67M+28.32%N/A
MNMD$0.00-$92.57M-$95.73MN/AN/A
View Top Biotech Stocks

ADCT earnings dates

Next earnings date
Jun 13, 2024

Adc Therapeutics Sa Earnings & Revenue FAQ

What were ADCT's earnings last quarter?

On Invalid Date, Adc Therapeutics Sa (NYSE: ADCT) reported Q4 2023 earnings per share (EPS) of -$1.05, up 238.71% year over year. Total Adc Therapeutics Sa earnings for the quarter were -$85.70 million. In the same quarter last year, Adc Therapeutics Sa's earnings per share (EPS) was -$0.31.

If you're new to stock investing, here's how to buy Adc Therapeutics Sa stock.

What was ADCT's earnings growth in the past year?

As of Q2 2024, Adc Therapeutics Sa's earnings has grown year over year. Adc Therapeutics Sa's earnings in the past year totalled -$240.05 million.

What is ADCT's earnings date?

Adc Therapeutics Sa's earnings date is Invalid Date. Add ADCT to your watchlist to be reminded of ADCT's next earnings announcement.

What was ADCT's revenue last quarter?

On Invalid Date, Adc Therapeutics Sa (NYSE: ADCT) reported Q4 2023 revenue of $16.79 million up 75.94% year over year. In the same quarter last year, Adc Therapeutics Sa's revenue was $69.80 million.

What was ADCT's revenue growth in the past year?

As of Q2 2024, Adc Therapeutics Sa's revenue has grown -66.86% year over year. This is 211.49 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Adc Therapeutics Sa's revenue in the past year totalled $69.56 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.